Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 239

Results For "treatment"

3729 News Found

Advanced library amplification mix delivers superior NGS data quality
Digitisation | April 14, 2023

Advanced library amplification mix delivers superior NGS data quality

NGS enables researchers to quickly sequence entire genomes and transcriptomes of organisms.


Max Healthcare Institute completes acquisition of further stake in Eqova Healthcare
Healthcare | April 14, 2023

Max Healthcare Institute completes acquisition of further stake in Eqova Healthcare

The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova


ProBioGen and ImmunOs Therapeutics join hands to deliver innovative therapy for cancer patients
News | April 13, 2023

ProBioGen and ImmunOs Therapeutics join hands to deliver innovative therapy for cancer patients

ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic.


Mandaviya inaugurates Robotic Surgery and AI Department at Yashoda Hospital, Ghaziabad
News | April 12, 2023

Mandaviya inaugurates Robotic Surgery and AI Department at Yashoda Hospital, Ghaziabad

The session took place in the presence of Union Ministers Hardeep Singh Puri and Gen V K Singh along with Anil Agarwal, Rajya Sabha Member of Parliament


LyGenesis and Imagine Pharma to jointly develop cell therapies for Patients with Type 1 diabetes
News | April 12, 2023

LyGenesis and Imagine Pharma to jointly develop cell therapies for Patients with Type 1 diabetes

Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes


CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells
News | April 12, 2023

CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells

CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells


Cipla signs agreement with Novartis for diabetes therapy Galvus range
News | April 11, 2023

Cipla signs agreement with Novartis for diabetes therapy Galvus range

Galvus has the potential to contribute significantly to Cipla’s portfolio in the diabetes care continuum space with reported sales of Rs. 268 crore


Shilpa Medicare receives USFDA approval for Psoriatic Arthritis Drug
Drug Approval | April 11, 2023

Shilpa Medicare receives USFDA approval for Psoriatic Arthritis Drug

Apremilast Tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene.


Need of the hour is Indian Research, Data and Solution to Indian problems: Dr Jitendra Singh
News | April 10, 2023

Need of the hour is Indian Research, Data and Solution to Indian problems: Dr Jitendra Singh

He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir


Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023
News | April 08, 2023

Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023

The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.